A PEGylation-Free biomimetic porphyrin banoplatform for personalized cancer theranostics

ACS Nano

Volumn 9, Issue 4, 2015, Pages 4484-4495

  Cui, Liyang ^a,b,c   Lin, Qiaoya ^a,d   Jin, Cheng S ^a,e,f   Jiang, Wenlei ^a   Huang, Huang ^a   Ding, Lili ^a   Muhanna, Nidal ^a,e   Irish, Jonathan C ^a,e   Wang, Fan ^c   Chen, Juan ^a   Zheng, Gang ^a,b,e,f  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PEKING UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

fluorescence guided surgery; multimodal imaging; nanoparticle; PEGylation; PET imaging; photodynamic therapy; porphyrin

Indexed keywords

BIOMIMETICS; CARDIOVASCULAR SYSTEM; CHEMOTHERAPY; DISEASES; FLUORESCENCE; INFRARED DEVICES; LIPOPROTEINS; NANOPARTICLES; NANOSTRUCTURES; PORPHYRINS; POSITRON EMISSION TOMOGRAPHY; SURGERY; TUMORS;

GUIDED SURGERY; MULTI-MODAL IMAGING; NEAR INFRARED (NIR) FLUORESCENCE IMAGING; PEGYLATION; PET IMAGING; PHOTODYNAMIC THERAPY (PDT); POSITRON EMISSION TOMOGRAPHY (PET); RETICULOENDOTHELIAL SYSTEMS;

PHOTODYNAMIC THERAPY;

APOLIPOPROTEIN A1; BIOMIMETIC MATERIAL; PORPHYRIN;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER ASSISTED SURGERY; FEMALE; FLUORESCENCE IMAGING; HUMAN; MALE; MOUSE; NEOPLASMS; PATHOLOGY; PERSONALIZED MEDICINE; PHOTOCHEMOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROTEIN SECONDARY STRUCTURE; THERANOSTIC NANOMEDICINE; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; APOLIPOPROTEIN A-I; BIOMIMETIC MATERIALS; CELL LINE, TUMOR; FEMALE; HUMANS; MALE; MICE; MODELS, MOLECULAR; NEOPLASMS; OPTICAL IMAGING; PHOTOCHEMOTHERAPY; PORPHYRINS; POSITRON-EMISSION TOMOGRAPHY; PRECISION MEDICINE; PROTEIN STRUCTURE, SECONDARY; SURGERY, COMPUTER-ASSISTED; THERANOSTIC NANOMEDICINE; TISSUE DISTRIBUTION;

EID: 84929120166     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.5b01077     Document Type: Article

References (65)

1. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the Epr Effect in Macromolecular Therapeutics: A Review J. Controlled Release 2000, 65, 271-284
2. Liu, J.; Bu, W.; Pan, L.; Shi, J. NiR-Triggered Anticancer Drug Delivery by Upconverting Nanoparticles with Integrated Azobenzene-Modified Mesoporous Silica Angew. Chem., Int. Ed. Engl. 2013, 52, 4375-4379
3. Xie, J.; Xu, C.; Kohler, N.; Hou, Y.; Sun, S. Controlled Pegylation of Monodisperse Fe3O4 Nanoparticles for Reduced Non-Specific Uptake by Macrophage Cells Adv. Mater. 2007, 19, 3163-3166
4. Wuelfing, W. P.; Gross, S. M.; Miles, D. T.; Murray, R. W. Nanometer Gold Clusters Protected by Surface-Bound Monolayers of Thiolated Poly(Ethylene Glycol) Polymer Electrolyte J. Am. Chem. Soc. 1998, 120, 12696-12697
5. Maltzahn, G.; Park, J.; Agrawal, A.; Bandaru, N. K.; Das, S. K.; Sailor, M. J.; Bhatia, S. N. Computationally Guided Photothermal Tumor Therapy Using Long-Circulating Gold Nanorod Antennas Cancer Res. 2009, 69, 3892-3900
6. Qian, X.; Peng, X.; Ansari, D. O.; Yin-Goen, Q.; Chen, G. Z.; Shin, D. M.; Yang, L.; Young, A. N.; Wang, M. D.; Nie, S. In Vivo Tumor Targeting and Spectroscopic Detection with Surface-Enhanced Raman Nanoparticle Tags Nat. Biotechnol. 2008, 26, 83-90
7. Koole, R.; van Schooneveld, M. M.; Hilhorst, J.; Castermans, K.; Cormode, D. P.; Strijkers, G. J.; de Mello Donegá, C.; Vanmaekelbergh, D.; Griffioen, A. W.; Nicolay, K. et al. Paramagnetic Lipid-Coated Silica Nanoparticles with a Fluorescent Quantum Dot Core: A New Contrast Agent Platform for Multimodality Imaging Bioconjugate Chem. 2008, 19, 2471-2479
8. Yoon, T.; Yu, K.; Kim, E.; Kim, J.; Kim, B.; Yun, S.; Sohn, B.; Cho, M.; Lee, J.; Park, S. Specific Targeting, Cell Sorting, and Bioimaging with Smart Magnetic Silica Core-Shell Nanomaterials Small 2006, 2, 209-215
9. Liu, J.; Yu, M.; Ning, X.; Zhou, C.; Yang, S.; Zheng, J. Pegylation and Zwitterionization: Pros and Cons in the Renal Clearance and Tumor Targeting of Near-IR-Emitting Gold Nanoparticles Angew. Chem., Int. Ed. Engl. 2013, 52, 12572-12576
10. Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Biodegradable Long-Circulating Polymeric Nanospheres Science 1994, 263, 1600-1603
11. Park, J. Liposome-Based Drug Delivery in Breast Cancer Treatment Breast Cancer Res. 2002, 4, 95-99
12. Peracchia, M. T.; Fattal, E.; Desmaële, D.; Besnard, M.; Noël, J. P.; Gomis, J. M.; Appel, M.; dAngelo, J.; Couvreur, P. Stealth® Pegylated Polycyanoacrylate Nanoparticles for Intravenous Administration and Splenic Targeting J. Controlled Release 1999, 60, 121-128
13. Otsuka, H.; Nagasaki, Y.; Kataoka, K. Pegylated Nanoparticles for Biological and Pharmaceutical Applications Adv. Drug Delivery Rev. 2003, 55, 403-419
14. Lovell, J. F.; Jin, C. S.; Huynh, E.; Jin, H.; Kim, C.; Rubinstein, J. L.; Chan, W. C.; Cao, W.; Wang, L. V.; Zheng, G. Porphysome Nanovesicles Generated by Porphyrin Bilayers for Use as Multimodal Biophotonic Contrast Agents Nat. Mater. 2011, 10, 324-332
15. Amoozgar, Z.; Yeo, Y. Recent Advances in Stealth Coating of Nanoparticle Drug Delivery Systems Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2012, 4, 219-233
16. Mishra, S.; Webster, P.; Davis, M. E. Pegylation Significantly Affects Cellular Uptake and Intracellular Trafficking of Non-Viral Gene Delivery Particles Eur. J. Cell Biol. 2004, 83, 97-111
17. Hatakeyama, H.; Akita, H.; Harashima, H. A Multifunctional Envelope Type Nano Device (Mend) for Gene Delivery to Tumours Based on the Epr Effect: A Strategy for Overcoming the Peg Dilemma Adv. Drug Delivery Rev. 2011, 63, 152-160
18. Hong, R.; Huang, C.; Tseng, Y.; Pang, V.; Chen, S.; Liu, J.; Chang, F. Direct Comparison of Liposomal Doxorubicin with or without Polyethylene Glycol Coating in C-26 Tumor-Bearing Mice: Is Surface Coating with Polyethylene Glycol Beneficial? Clin. Cancer Res. 1999, 5, 3645-3652
19. Moghimi, S. M.; Hamad, I.; Andresen, T. L.; Jørgensen, K.; Szebeni, J. Methylation of the Phosphate Oxygen Moiety of Phospholipid-Methoxy(Polyethylene Glycol) Conjugate Prevents Pegylated Liposome-Mediated Complement Activation and Anaphylatoxin Production FASEB J. 2006, 20, 2591-2593
20. Hamad, I.; Hunter, A. C.; Szebeni, J.; Moghimi, S. M. Poly(Ethylene Glycol)s Generate Complement Activation Products in Human Serum through Increased Alternative Pathway Turnover and a MASP-2-Dependent Process Mol. Immunol. 2008, 46, 225-232
21. Ishida, T.; Maeda, R.; Ichihara, M.; Irimura, K.; Kiwada, H. Accelerated Clearance of Pegylated Liposomes in Rats after Repeated Injections J. Controlled Release 2003, 88, 35-42
22. Ishida, T.; Ichihara, M.; Wang, X.; Yamamoto, K.; Kimura, J.; Majima, E.; Kiwada, H. Injection of PEGylated Liposomes in Rats Elicits PEG-Specific Igm, Which Is Responsible for Rapid Elimination of a Second Dose of PEGylated Liposomes J. Controlled Release 2006, 112, 15-25
23. Dams, E. T. M.; Laverman, P.; Oyen, W. J. G.; Storm, G.; Scherphof, G. L.; van der Meer, J. W. M.; Corstens, F. H. M.; Boerman, O. C. Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes J. Pharmacol. Exp. Ther. 2000, 292, 1071-1079
24. Robert, N. J.; Vogel, C. L.; Henderson, I. C.; Sparano, J. A.; Moore, M. R.; Silverman, P.; Overmoyer, B. A.; Shapiro, C. L.; Park, J. W.; Colbern, G. T. et al. The Role of the Liposomal Anthracyclines and Other Systemic Therapies in the Management of Advanced Breast Cancer Semin. Oncol. 2004, 31, 106-146
25. Duncan, R.; Gaspar, R. Nanomedicine(s) under the Microscope Mol. Pharmaceutics 2011, 8, 2101-2141
26. MacEwan, S. R.; Callahan, D. J.; Chilkoti, A. Stimulus-Responsive Macromolecules and Nanoparticles for Cancer Drug Delivery Nanomedicine 2010, 5, 793-806
27. Vllasaliu, D.; Fowler, R.; Stolnik, S. Pegylated Nanomedicines: Recent Progress and Remaining Concerns Expert Opin. Drug Delivery 2014, 11, 139-154
28. Chambers, E.; Mitragotri, S. Prolonged Circulation of Large Polymeric Nanoparticles by Non-Covalent Adsorption on Erythrocytes J. Controlled Release 2004, 100, 111-119
29. Eisenberg, S.; Windmueller, H. G.; Levy, R. I. Metabolic Fate of Rat and Human Lipoprotein Apoproteins in the Rat J. Lipid Res. 1973, 14, 446-458
30. Ng, K. K.; Lovell, J. F.; Zheng, G. Lipoprotein-Inspired Nanoparticles for Cancer Theranostics Acc. Chem. Res. 2011, 44, 1105-1113
31. Corbin, I. R.; Zheng, G. Mimicking Nature Nanocarrier: Synthetic Low-Density Lipoprotein-Like Nanoparticles for Cancer-Drug Delivery Nanomedicine 2007, 2, 375-380
32. Zhang, Z.; Cao, W.; Jin, H.; Lovell, J. F.; Yang, M.; Ding, L.; Chen, J.; Corbin, I.; Luo, Q.; Zheng, G. Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery Angew. Chem., Int. Ed. Engl. 2009, 48, 9171-9175
33. Cormode, D. P.; Frias, J. C.; Ma, Y.; Chen, W.; Skajaa, T.; Briley-Saebo, K.; Barazza, A.; Williams, K. J.; Mulder, W. J.; Fayad, Z. A.; Fisher, E. A. HDL as a Contrast Agent for Medical Imaging Clin. Lipidol. 2009, 4, 493-500
34. Bricarello, D. A.; Smilowitz, J. T.; Zivkovic, A. M.; German, J. B.; Parikh, A. N. Reconstituted Lipoprotein: A Versatile Class of Biologically-Inspired Nanostructures ACS Nano 2011, 5, 42-57
35. Huang, H.; Cruz, W.; Chen, J.; Zheng, G. Learning from Biology: Synthetic Lipoproteins for Drug Delivery Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2014, 10.1002/wnan.1308
36. Marrache, S.; Dhar, S. Biodegradable Synthetic High-Density Lipoprotein Nanoparticles for Atherosclerosis Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 9445-9450
37. Foit, L.; Giles, F. J.; Gordon, L. I.; Thaxton, C. S. Synthetic High-Density Lipoprotein-Like Nanoparticles for Cancer Therapy Expert Rev. Anticancer Ther. 2015, 15, 27-34
38. Allijn, I. E.; Leong, W.; Tang, J.; Gianella, A.; Mieszawska, A. J.; Fay, F.; Ma, G.; Russell, S.; Callo, C. B.; Gordon, R. E. et al. Gold Nanocrystal Labeling Allows Low-Density Lipoprotein Imaging from the Subcellular to Macroscopic Level ACS Nano 2013, 7, 9761-9770
39. Cormode, D. P.; Skajaa, T.; van Schooneveld, M. M.; Koole, R.; Jarzyna, P.; Lobatto, M. E.; Calcagno, C.; Barazza, A.; Gordon, R. E.; Zanzonico, P. et al. Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform Nano Lett. 2008, 8, 3715-3723
40. Saxena, V. P.; Wetlaufer, D. B. A New Basis for Interpreting the Circular Dichroic Spectra of Proteins Proc. Natl. Acad. Sci. U. S. A. 1971, 68, 969-972
41. Zhang, Z.; Chen, J.; Ding, L.; Jin, H.; Lovell, J. F.; Corbin, I. R.; Cao, W.; Lo, P. C.; Yang, M.; Tsao, M. S. et al. HDL-Mimicking Peptide-Lipid Nanoparticles with Improved Tumor Targeting Small 2010, 6, 430-437
42. Jin, C. S.; Lovell, J. F.; Chen, J.; Zheng, G. Ablation of Hypoxic Tumors with Dose-Equivalent Photothermal, but Not Photodynamic, Therapy Using a Nanostructured Porphyrin Assembly ACS Nano 2013, 7, 2541-2550
43. Zhan, C.; Lu, W. The Blood-Brain/Tumor Barriers: Challenges and Chances for Malignant Gliomas Targeted Drug Delivery Curr. Pharm. Biotechnol. 2012, 13, 2380-2387
44. Stukel, J. M.; Caplan, M. R. Targeted Drug Delivery for Treatment and Imaging of Glioblastoma Multiforme Expert Opin. Drug Delivery 2009, 6, 705-718
45. Bechet, D.; Mordon, S. R.; Guillemin, F.; Barberi-Heyob, M. A. Photodynamic Therapy of Malignant Brain Tumours: A Complementary Approach to Conventional Therapies Cancer Treat. Rev. 2014, 40, 229-241
46. Muller, P. J.; Wilson, B. C. Photodynamic Therapy of Brain Tumorsa Work in Progress Lasers Surg. Med. 2006, 38, 384-389
47. Wilson, T. A.; Karajannis, M. A.; Harter, D. H. Glioblastoma Multiforme: State of the Art and Future Therapeutics Surg. Neurol. Int. 2014, 5, 64
48. Eyupoglu, I. Y.; Buchfelder, M.; Savaskan, N. E. Surgical Resection of Malignant Gliomas-Role in Optimizing Patient Outcome Nat. Rev. Neurol. 2013, 9, 141-151
49. Hassaneen, W.; Levine, N. B.; Suki, D.; Salaskar, A. L.; de Moura Lima, A.; McCutcheon, I. E.; Prabhu, S. S.; Lang, F. F.; DeMonte, F.; Rao, G. et al. Multiple Craniotomies in the Management of Multifocal and Multicentric Glioblastoma. Clinical Article J. Neurosurg. 2011, 114, 576-584
50. MacDonald, T. D.; Liu, T. W.; Zheng, G. An MRI-Sensitive, Non-Photobleachable Porphysome Photothermal Agent Angew. Chem., Int. Ed. Engl. 2014, 53, 6956-6959
51. Lin, Q.; Chen, J.; Jin, H.; Ng, K. K.; Yang, M.; Cao, W.; Ding, L.; Zhang, Z.; Zheng, G. Efficient Systemic Delivery of Sirna by Using High-Density Lipoprotein-Mimicking Peptide Lipid Nanoparticles Nanomedicine 2012, 7, 1813-1825
52. Lin, Q.; Chen, J.; Zhang, Z.; Zheng, G. Lipid-Based Nanoparticles in the Systemic Delivery of Sirna Nanomedicine 2014, 9, 105-120
53. Shahzad, M. M.; Mangala, L. S.; Han, H. D.; Lu, C.; Bottsford-Miller, J.; Nishimura, M.; Mora, E. M.; Lee, J. W.; Stone, R. L.; Pecot, C. V. et al. Targeted Delivery of Small Interfering Rna Using Reconstituted High-Density Lipoprotein Nanoparticles Neoplasia 2011, 13, 309-319
54. Rui, M.; Tang, H.; Li, Y.; Wei, X.; Xu, Y. Recombinant High Density Lipoprotein Nanoparticles for Target-Specific Delivery of Sirna Pharm. Res. 2013, 30, 1203-1214
55. McConathy, W. J.; Nair, M. P.; Paranjape, S.; Mooberry, L.; Lacko, A. G. Evaluation of Synthetic/Reconstituted High-Density Lipoproteins as Delivery Vehicles for Paclitaxel Anti-Cancer Drugs 2008, 19, 183-188
56. Yang, M.; Chen, J.; Cao, W.; Ding, L.; Ng, K. K.; Jin, H.; Zhang, Z.; Zheng, G. Attenuation of Nontargeted Cell-Kill Using a High-Density Lipoprotein-Mimicking Peptide-Phospholipid Nanoscaffold Nanomedicine 2011, 6, 631-641
57. Duivenvoorden, R.; Tang, J.; Cormode, D. P.; Mieszawska, A. J.; Izquierdo-Garcia, D.; Ozcan, C.; Otten, M. J.; Zaidi, N.; Lobatto, M. E.; van Rijs, S. M. et al. A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation Nat. Commun. 2014, 5, 3065
58. Jin, C. S.; Cui, L.; Wang, F.; Chen, J.; Zheng, G. Targeting-Triggered Porphysome Nanostructure Disruption for Activatable Photodynamic Therapy Adv. Healthcare Mater. 2014, 3, 1240-1249
59. Perrault, S. D.; Walkey, C.; Jennings, T.; Fischer, H. C.; Chan, W. C. Mediating Tumor Targeting Efficiency of Nanoparticles through Design Nano Lett. 2009, 9, 1909-1915
60. Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami, M.; Kimura, M.; Terada, Y.; Kano, M. R.; Miyazono, K.; Uesaka, M.; Nishiyama, N.; Kataoka, K. Accumulation of Sub-100 nm Polymeric Micelles in Poorly Permeable Tumours Depends on Size Nat. Nanotechnol. 2011, 6, 815-823
61. Yuan, F.; Leunig, M.; Huang, S. K.; Berk, D. A.; Papahadjopoulos, D.; Jain, R. K. Microvascular Permeability and Interstitial Penetration of Sterically Stabilized (Stealth) Liposomes in a Human Tumor Xenograft Cancer Res. 1994, 54, 3352-3356
62. Davis, M. E.; Chen, Z. G.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
63. Cheng, L.; Wang, C.; Feng, L.; Yang, K.; Liu, Z. Functional Nanomaterials for Phototherapies of Cancer Chem. Rev. 2014, 114, 10869-10939
64. Chapman, M. J. Animal Lipoproteins: Chemistry, Structure, and Comparative Aspects J. Lipid Res. 1980, 21, 789-853
65. Liu, T. W.; MacDonald, T.; Shi, J.; Wilson, B. C.; Zheng, G. Intrinsically Copper-64-Labeled Organic Nanoparticles as Radiotracers Angew. Chem., Int. Ed. Engl. 2012, 51, 1-5